Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans
- 1 August 1997
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 46 (8) , 1328-1335
- https://doi.org/10.2337/diabetes.46.8.1328
Abstract
The aim of the study was to determine the effects of specific levels of antecedent hypoglycemia on subsequent autonomic, neuroendocrine, and metabolic counterregulatory responses. Eight healthy, overnight-fasted male subjects were studied during a-day protocols on four separate randomized occasions separated by at least 2 months. On day 1, insulin was infused at a rate of 9 pmol.kg(-1).min(-1) and 2-h clamped euglycemia (plasma glucose 5.2 +/- 0.2 mmol/l) or differing hypoglycemia (plasma glucose 3.9 +/- 0.1, 3.3 +/- 0.1, or 2.9 +/- 0.1 mmol/l) was obtained during morning and afternoon. The next morning after an evening meal and 10-h overnight fast, each subject underwent a 2-h hyperinsulinemic (9 pmol.kg(-1).min(-1)) hypoglycemic (2.9 +/- 0.1 mmol/l) clamp study. Despite equivalent day 2 plasma glucose and insulin levels, differing levels of antecedent hypoglycemia produced specific blunting of subsequent counterregulatory responses. Day 1 hypoglycemia of 3.9 mmol/l resulted in significantly (P < 0.01) blunted epinephrine, muscle sympathetic nerve activity, and glucagon responses. Day 1 hypoglycemia of 3.3 mmol/l resulted in additional significant blunting (P < 0.01) of pancreatic: polypeptide, norepinephrine, growth hormone, endogenous glucose production, and lipolytic responses. Deeper day 1 hypoglycemia of 2.9 mmol/l produced similar day 2 counterregulatory failure as day 1 hypoglycemia of 3.3 mmol/l. In summary, in healthy overnight-fasted men, mild antecedent hypoglycemia of 3.9 mmol/l significantly blunts sympathoadrenal and glucagon, but not other forms of neuroendocrine counterregulatory responses, to subsequent hypoglycemia. Antecedent hypoglycemia of 3.3 mmol/l resulted in additional significant blunting of all major neuroendocrine and metabolic responses to subsequent hypoglycemia. We conclude that in normal humans, there is a hierarchy of blunted counterregulatory responses that are determined by the depth of antecedent hypoglycemia.This publication has 14 references indexed in Scilit:
- Changes of sympathetic nerve activity induced by 2-deoxy-D-glucose infusion in humansAmerican Journal of Physiology-Endocrinology and Metabolism, 1989
- Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious dogsDiabetes, 1988
- Defective Glucose Counterregulation after Strict Glycemic Control of Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1987
- Predominance of renal and absence of hepatic metabolism of pancreatic polypeptide in the dogAmerican Journal of Physiology-Endocrinology and Metabolism, 1983
- Assay of plasma catecholamines by liquid chromatography with electrochemical detectionAnalytical Biochemistry, 1981
- Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in manMetabolism, 1981
- Plasma noradrenaline correlates to sympathetic muscle nerve activity in normotensive manActa Physiologica Scandinavica, 1981
- Glucose clamp technique: a method for quantifying insulin secretion and resistance.American Journal of Physiology-Endocrinology and Metabolism, 1979
- Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate.Clinical Chemistry, 1978
- Effect of glucagon on glucose production during insulin deficiency in the dog.Journal of Clinical Investigation, 1978